Ownership and use of tissue specimens for research

JAMA

Volumn 292, Issue 20, 2004, Pages 2500-2505

  Hakimian, Rina ^a,b   Korn, David ^a  

^a ASSOCIATION OF AMERICAN MEDICAL COLLEGES   (United States)

^b U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE FACILITY; HEALTH CARE POLICY; HUMAN RIGHTS; LAW; MEDICAL ETHICS; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW; TISSUE;

EID: 9244257861     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.292.20.2500     Document Type: Review

References (42)

1. Korn D. Contribution of the human tissue archive to the advancement of medical knowledge and the public health. In: Research Involving Human Biological Materials: Ethical Issues and Policy Guidance. Vol II. Rockville, Md: National Bioethics Advisory Commission; 2000.
2. Barker A, Strategic Scientific Initiatives, National Cancer Institute, AAMC. Meeting of the Advisory Panel on Research. Presented at Association of American Medical Colleges; May 5, 2004; Rockville, Md.
3. Fla Stat Ann §760.40 (West 2003).
4. Moore v Regents of the University of California, 51 Cal3d 120, 793 P2d 479, 271 Cal Rptr 146 (1990), cert denied, 499 US 936 (1991).
5. 45 CFR part 46, subpart A (2002).
6. 21 CFR part 50, part 56 (2002).
7. 45 CFR part 46.101(b)(4) (2002).
8. 45 CFR part 46.102(f) (2002).
9. US Department of Health and Human Services; Office for Human Research Protections. Issues to consider in the research use of stored data or tissues. Available at: http://www.hhs.gov/ohrp/humansubjects/guidance/reposit.htm. Accessibility verified October 20, 2004.
10. Barnes M, Heffernan K. "Future uses" dilemma: secondary uses of data and materials by researchers and commercial research. Med Res Law Policy. 2004;3:440-452.
11. US Office of Technology Assessment. New Developments in Biotechnology: Ownership of Human Tissues and Cells: Special Report. Washington, DC: US Government Printing Office; 1987. Publication OTA-BA-337.
12. US Food and Drug Administration. Guidance for institutional review boards and clinical investigators [question 52]. Available at: http://www.fda.gov/oc/ ohrt /irbs/faqs.html. Accessibility verified October 20, 2004.
13. 45 CFR part 46.116 (2002).
14. US Department of Health and Human Services; Office for Human Research Protections. Exculpatory language in informed consent documents. Available at: http://www.hhs.gov/ohrp/humansubjects/guidance/exculp.htm. Accessibility verified October 20, 2004.
15. Greenberg, 2003 WL 21246347 (So2d, May 29, 2003).
16. Hakimian R, Taube S, Bledsoe M, Aamodt R. 50-State Survey of Laws Regulating the Collection, Storage, and Use of Human Tissue Specimens and Associated Data for Research. Rockville, Md: National Cancer Institute. In press.
17. National Conference of State Legislatures. Table of state genetic privacy laws. Available at: http://www.ncsl.org/programs/health/genetics/prt.htm. Accessibility verified October 20, 2004.
18. Annas GJ, Glantz LH, Roche PA. Genetic Privacy Act and commentary. Available at: http://www.ornl.gov/sci/techresources/Human_Genome/resource/ privacy /privacy1.html. Accessibility verified October 20, 2004.
19. National Institutes of Health/National Human Genome Research Institute. Report of the Joint NIH/DOE Committee to evaluate the ethical, legal, and social implications program of the Human Genome Project. Available at: http://www .genome.gov/10001745. Accessibility verified October 20, 2004.
20. Murray TH. Genetic exceptionalism and "future diaries": is genetic information different from other medical information? In: Rothstein MA, ed. Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era. New Haven, Conn: Yale University Press; 1997:60-73.
21. Gostin LO, Hodge JG Jr. Genetic privacy and the law: an end to genetics exceptionalism. Jurimetrics J. 1999;40:21-58.
22. Health Insurance Portability and Accountability Act of 1996. Pub L No. 104-191, §264(1996).
23. Standards for Privacy of Individually Identifiable Health Information, 45 CFR §160(2002).
24. 45 CFR §164 subparts A, E (2002).
25. Transcript of the March 30, 2004 meeting of the Secretary's Advisory Committee for Human Research Protections. Available at: http://www.hhs.gov/ohrp /sachrp/mtgings/mtg03-04/min0330.html. Accessibility verified October 20, 2004.
26. Diamond v Chakrabarty, 447 US 303, 309-310, 65 LEd2d 144, 150, 100 SCt 2204 (1980).
27. Washington University v Catalona, Case No. 4:03CV01065-SNL (ED Mo, filed August 4, 2003).
28. Tilousi, No. CV2004-0115 (Ariz February 25, 2004).
29. Havasupai Tribe, No. CV2004-0146 (Ariz March 12, 2004).
30. Eiseman E, Haga S. Handbook of Human Tissue Sources: A National Resource of Human Tissue Samples. Santa Monica, Calif: RAND; 1999.
31. Winickoff DE, Winikoff R. Charitable trust as a model for genomic biobanks. N Engl J Med. 2003;349:1180-1184.
32. Kass NE, Natowicz MR. Use of medical records in research: what do patients want? J Law Med Ethics. 2003;31:429-433.
33. Jack LA, Womack C. Why surgical patients do not donate tissue for commercial research: review of records. BMJ. 2003;327:262.
34. Parties have reached a settlement in Greenberg et al v Miami Children's Hospital Research Institute et al [press release]. New York, NY: Canavan Foundation; September 29, 2003. Available at: http://www.canavanfoundation.org/ news /09-03_miami.php. Accessibility verified October 20, 2004.
35. PXE International Inc Web site Available at: http://www.pxe.org/research .html. Accessibility verified October 20, 2004.
36. Association of American Universities. Report on individual and institutional financial conflict of interest. Available at: http://www.aau.edu/ research/COI.01 .pdf. Accessibility verified October 20, 2004.
37. Association of American Medical Colleges. Protecting subjects, preserving trust, promoting progress: policy and guidelines for the oversight of individual financial interests in human subjects research. Available at: http://www.aamc.org/members /coitf/firstreport.pdf. Accessibility verified October 20, 2004.
38. Association of American Medical Colleges. Protecting subjects, preserving trust, promoting progress, II: principles and recommendations for the oversight of an institution's financial interests in human subjects research. Available at: http://www .aamc.org/members/coitf/2002coireport.pdf. Accessibility verified October 20,2004.
39. US Department of Health and Human Services; Office for Human Research Protections. Financial relationships and interests in research involving human subjects: guidance for human subject protection. Available at: http://www.hhs.gov /ohrp/humansubjects/finreltn/fguid.pdf. Accessibility verified October 20, 2004.
40. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. Ethical principles and guidelines for the protection of human subjects of research. Available at: http://www.hhs.gov/ohrp/humansubjects /guidance/belmont.htm. Accessibility verified October 20, 2004.
41. Korn D. Genetic Testing and the Use of Information. Washington, DC: AEJ Press; 1999.
42. Korn D. Medical information privacy and the conduct of biomedical research. Acad Med. 2000;75:963-968.